Professor Andrew Dick appointed as Dean of Brain Sciences

Professor Andrew Dick has been appointed as the next Dean of the UCL Faculty of Brain Sciences, taking up the role in September 2026. A leading specialist in eye disease and ocular immunology, he succeeds Professor Alan Thompson, who has served as Dean since the faculty was established in 2011.

Professor Dick currently holds the Duke Elder Chair and is Director of the UCL Institute of Ophthalmology. He also serves as co-Director of the NIHR Moorfields Biomedical Research Centre. His research has focused on inflammatory and degenerative eye diseases, with findings that have shaped international clinical practice, particularly through the development of biologic therapies for severe inflammatory eye conditions.

Since joining UCL in 2015, Professor Dick has overseen a period of significant expansion at the Institute of Ophthalmology, strengthening its global standing in vision research and translational medicine. He has also played a major role in advancing collaborations between academia, the NHS and industry, while promoting interdisciplinary research and professional development across the institution.

A key part of his recent leadership has involved the development of the Moorfields and UCL Centre for Eye Health, a major new facility due to open in 2027 in St Pancras, designed to bring together patient care, education and scientific research under one roof.

| Sign up to the ACNR email newsletter here |

UCL leaders praised the appointment, highlighting Professor Dick’s extensive experience across research, teaching and clinical partnerships. In accepting the post, he said he looked forward to building on the faculty’s international reputation, supporting staff and students, and strengthening collaborations with healthcare partners, industry and policymakers.

Professor Thompson, a renowned neurologist recognised for his work in multiple sclerosis, said he was pleased to hand over leadership to an experienced internal successor who could guide the faculty through its next phase of growth.

This news item has been summarised using AI and checked by humans before publication.


Sources

UCL News

| Sign up for our online community for neurology specialists |